Sanofi says FDA delays weight-loss drug decision
293619
Sanofi-Aventis said on Monday that U.S. health regulators have extended by three months their decision on whether to approve the French drugmaker's highly anticipated weight loss drug, Acomplia.
693013
A U.S. judge has granted a request from  Sanofi-Aventis and U.S. partner Bristol-Myers Squibb Co.   to block the sale in the United States of a generic  form of its top selling blood-thinner Plavix, giving a boost to  shares in the French drugmaker on Friday.
565009
Some of the health benefits claimed for a new weight loss drug may not be justified, say experts.
524021
Merck & Co.  said on Friday it would delay seeking approval for a combination pill designed to lower "bad" cholesterol, increase "good" cholesterol and avoid a common side effect of one of the ingredients.
13024
U.S. regulators have asked for more data on Novartis AG's  diabetes drug Galvus, possibly delaying approval of the potential blockbuster by a year, which dented its shares while boosting its main rival's.
454185
GlaxoSmithKline PLC revealed Thursday that the U.S. Food and Drug Administration has declined to grant a priority review to its experimental cancer vaccine Cervarix, adding to pressure on the drug maker after controversy surrounding its diabetes drug Avandia.
249030
Sanofi-Aventis SA is withdrawing its application to sell obesity drug rimonabant -- its biggest new drug hope -- in the United States, the French drugmaker said on Friday.
300123
The Food and Drug Administration announcement comes as a response to criticism that the government has reacted too slowly to the dangers posed by popular supplements.
224422
New reports accuse another drug company of being too slow to pull a dangerous medication from the market and question the ability of the US federal Food and Drug Administration to protect Americans from such risks.
165609
A federal panel delayed a vote yesterday on whether to recommend MedImmune's nasal influenza vaccine, FluMist, for children under 5 years old, a key market for the Gaithersburg biotechnology firm.
26459
Drugmaker Sanofi-Aventis , the target of a lawsuit seeking class-action status filed on behalf of shareholders, on Friday vowed to fight allegations it hid the side-effects of its anti-obesity drug Acomplia.
42428
The government has delayed a decision about whether to allow women to buy the morning-after birth control pill over the counter but hopes to act soon, the manufacturer said Friday.
407294
The biotech company announces new drug delays.
64013
New reports accuse another drug company of being too slow to pull a dangerous medication from the market and question the ability of the federal Food and Drug Administration to protect the public from such risks.
424318
The French anti-doping agency postponed a decision Thursday on whether to suspend Tour de France winner Floyd Landis because of a positive doping test.
701012
The Food and Drug Administration  should delay a decision on whether milk and meat from some  cloned animals are safe to eat until additional safety studies  can be conducted, a Democratic lawmaker and consumer groups  said in separate statements on Tuesday.
12623
The Food and Drug Administration has told a researcher that he cannot be part of an advisory panel that will meet early next year to review the safety of a class of drugs, COX-2 inhibitors, used to treat arthritis and pain.